Calian Group (TSE:CGY – Get Free Report) had its price target lifted by ATB Cormark Capital Markets from C$92.50 to C$98.50 in a report issued on Tuesday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. ATB Cormark Capital Markets’ price target suggests a potential upside of 21.62% from the company’s previous close.
CGY has been the subject of several other research reports. Canadian Imperial Bank of Commerce increased their price objective on Calian Group from C$76.00 to C$90.00 in a report on Friday. Ventum Financial raised their price target on Calian Group from C$84.00 to C$94.00 and gave the company a “buy” rating in a report on Tuesday, March 10th. Canaccord Genuity Group raised their price target on Calian Group from C$63.00 to C$80.00 in a report on Friday, February 13th. Acumen Capital raised their price target on Calian Group from C$70.00 to C$85.00 and gave the company a “buy” rating in a report on Friday, February 13th. Finally, Royal Bank Of Canada raised their price target on Calian Group from C$78.00 to C$90.00 and gave the company an “outperform” rating in a report on Friday. Seven equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of C$86.21.
Get Our Latest Stock Analysis on CGY
Calian Group Stock Up 0.4%
Calian Group (TSE:CGY – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported C$1.30 EPS for the quarter. The company had revenue of C$228.70 million during the quarter. Calian Group had a return on equity of 10.35% and a net margin of 3.97%. On average, analysts expect that Calian Group will post 4.9475219 earnings per share for the current fiscal year.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Featured Stories
- Five stocks we like better than Calian Group
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
